In this article, we take a look at the 5 pharmaceutical stocks to buy according to Brandon Haley’s Holocene Advisors. If you want to check out our detailed analysis of Holocene Advisors’ 13F portfolio, go directly to 10 Pharmaceutical Stocks to Buy According to Brandon Haley’s Holocene Advisors.
5. Baxter International Inc. (NYSE:BAX)
Holocene Advisors’ Stake Value: $82.4 million
Percentage of Holocene Advisors’ 13F Portfolio: 0.44%
Number of Hedge Fund Holders: 42
Baxter International Inc. (NYSE:BAX) is an American international company based in Illinois. The company primarily focuses on development of solutions for various kidney diseases. Holocene Advisors owns over a million shares in the company after a bullish stake increase by 1904% in the third quarter of 2021. In the same quarter, the hedge fund Generation Investment Management was the leading stakeholder in the company with over 20 million shares making up 6.93% of their total portfolio.
The company filed a revenue of $3.23 billion in the same quarter with EPS of $1.02 beating analyst estimates by $0.08. On November 11, Baxter International Inc. (NYSE:BAX) announced a roughly $100M expansion of its sterile fill/finish manufacturing facility located in Germany. This facility is run by BioPharma Solutions, a business unit of Baxter International Inc. (NYSE:BAX) that specializes in partnering with foremost pharmaceutical and biotechnology companies on the development and contract-manufacturing of drug products for parenteral pharmaceuticals.